AgeLOC Ph 1 產品

Q2 2009 Earnings Call
July 29, 2009

Truman Hunt - President and Chief Executive Officer

Truman Hunt

Our results reflect improvement in two key markets in particular. We're pleased with year-over-year growth in Mainland China, which you may recall, we projected a couple of quarters ago. Andrew Fan and his team there are doing a great job is what continues to be a significant business model transition.

ageLOC has tremendous potential for our business. So I want to take just a moment and expose you a little bit to ageLOC into our product direction.

Phase 1 of ageLOC was announced with the discovery of the arNOX enzyme. This is a free radical producing enzyme. It significantly escalates aging in the skin as we get older. The Galvanic Spa gel which were launched last year include arNOX inhibitors. It generates significant improvement in the skin. But arNOX inhibition, as compelling as it is, it's really just a small part of the ageLOC story. The ultimate source of aging is found in the human genes. The way that our genes respond to aging and to all of the external and internal influences that way on our genes are what really dictate, how we age and how we look as we age.

So, that our conventional to whatever it will be unveiling much more of the sign behind ageLOC and we'll be launching our first ageLOC skin treatment system. This will be a four product system that includes a cleanser toner, a day cream, a night cream as well as the daily use serum.

The new skincare system will really be the flagship. The skincare system that we offer and will be offered in our highest price point versus other existing systems.

So, the three core components, the cleanser, toner, the day cream and the night cream will be offered for a price in the $100 range with the future serum, the mother of all serums being added on top of that and approximately be the $150 range.

The story associated with ageLOC is so different than other line and wrinkle stories that we think we're really opening up our whole new world of people, whom we can convince of the ageLOC's story and the fact that ageLOC products really are attacking the source of aging and not just the signs of aging to make them all the more compelling.



Read the Nu Skin Enterprises Q2 2009 Earnings Call Transcript.

"The new skincare system will really be the flagship."

我們的研究結果反映改善兩個主要市場，特別是。我們很高興與去年同期相比增長在中國內地，而你也許還記得，我們預計一季度前。安德魯範和他的團隊有正在進行一項偉大的工作是什麼仍然是一個重要的商業模式轉型。

ageLOC具有巨大的潛力為我們的業務。所以，我想等一下和揭露你一點點向ageLOC到我們的產品方向發展。

第1階段的ageLOC宣布發現了arNOX酶。這是自由基產生的酶。它大大升級老化的皮膚，因為我們變老。凝膠的電偶溫泉是去年推出的包括 arNOX抑製劑。它所產生顯著改善皮膚。但是arNOX抑製作用，因為它的吸引力是，它真的只是一小部分ageLOC故事。的最終來源老化中發現的人類基因。的方式，我們的基因應對老齡化以及所有的外部和內部影響，這種方式在我們的基因是真正發號施令，我們如何年齡和我們如何看待我們隨著年齡。

因此，我們的傳統的東西將推出更多的跡象背後ageLOC ，我們將推出我們的第一ageLOC皮膚治療系統。這將是一個4個產品體系，其中包括清潔碳粉，一個日霜，一個晚霜以及日常使用血清。

新的護膚系統將真正的旗艦。的護膚系統，我們提供和將提供我們的最高價位與其他現有的系統。

因此，這三個核心組成部分，清潔劑，碳粉的日霜和晚霜將推出價格在100美元的範圍與未來的血清，母親的所有血清日益增加的最重要的是，大約是150美元範圍。

這個故事與ageLOC是不同於其他的故事線和皺紋，我們認為我們真的開放，我們的全新世界的人，我們可以說服的ageLOC的故事和事實，即ageLOC產品真的是攻擊的來源，老齡化，而不僅僅是衰老的跡象，使它們更加引人注目。

via translate.google.com